# Treatment of Acute Pericarditis With Anakinra

> **NCT03224585** · PHASE2 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 5 (actual)

## Conditions studied

- Acute Pericarditis

## Interventions

- **DRUG:** Anakinra
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03224585
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-11
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Study was terminated because dramatic benefits seen during the first 24 hours of drug administration combined with COVID restrictions on research activities suggested it was both unethical and unnecessary to complete the planned enrollment
- **Last updated:** 2021-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03224585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03224585, "Treatment of Acute Pericarditis With Anakinra". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03224585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*